We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.93%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$14.4B
AUM Growth
-$406M
Cap. Flow
-$163M
Cap. Flow %
-1.13%
Top 10 Hldgs %
24.27%
Holding
957
New
98
Increased
341
Reduced
353
Closed
82

Top Buys

Rank Stock Value
1
BZ icon
Kanzhun
BZ
+$45.9M
2
STKL
SunOpta
STKL
+$45M
3
ZTO icon
ZTO Express
ZTO
+$44.4M
4
JPM icon
JPMorgan Chase
JPM
+$39.9M
5
XIFR
XPLR Infrastructure LP
XIFR
+$36.1M

Top Sells

Rank Stock Value
1
MELI icon
Mercado Libre
MELI
+$79.9M
2
MSFT icon
Microsoft
MSFT
+$58.5M
3
VERU icon
Veru
VERU
+$53.9M
4
PG icon
Procter & Gamble
PG
+$50.5M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$37M

Sector Composition

Rank Sector Weight
1 Healthcare 30.95%
2 Technology 26.5%
3 Financials 9.1%
4 Consumer Discretionary 8.02%
5 Industrials 7.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
M icon
251
Macy's
M
$6.51B
$10.5M 0.07%
652,614
+521,156
+396% +$11M
SCHW
252
Charles Schwab
SCHW
$182B
$10.4M 0.07%
215,584
+56,497
+36% +$4.14M
CAG icon
253
Conagra Brands
CAG
$7.42B
$10.3M 0.07%
296,529
+178,777
+152% +$6.62M
CI icon
254
Cigna
CI
$78.4B
$10.2M 0.07%
43,565
-6,747
-13% -$1.97M
PH icon
255
Parker-Hannifin
PH
$120B
$10.1M 0.07%
32,779
+10,966
+50% +$3.63M
KLAC icon
256
KLA
KLAC
$222B
$10.1M 0.07%
273,540
-26,800
-9% -$1.06M
CTSH icon
257
Cognizant
CTSH
$25.2B
$9.95M 0.07%
177,504
+109,717
+162% +$6.87M
FISV
258
Fiserv Inc
FISV
$29.7B
$9.79M 0.07%
94,115
+17,126
+22% +$1.88M
MRSH
259
Marsh
MRSH
$94.3B
$9.79M 0.07%
63,839
-2,634
-4% -$439K
RNR icon
260
RenaissanceRe
RNR
$13.8B
$9.63M 0.07%
52,212
-34,293
-40% -$6.9M
ATVI
261
DELISTED
Activision Blizzard
ATVI
$9.6M 0.07%
121,800
+5,476
+5% +$425K
RL icon
262
Ralph Lauren
RL
$22.4B
$9.58M 0.07%
+89,213
New +$10.5M
GE icon
263
GE Aerospace
GE
$364B
$9.55M 0.07%
135,927
-5,135
-4% -$344K
IOVA icon
264
Iovance Biotherapeutics
IOVA
$2.04B
$9.53M 0.07%
1,693,920
+140,000
+9% +$966K
COGT icon
265
Cogent Biosciences
COGT
$6.76B
$9.31M 0.06%
937,141
-60,000
-6% -$767K
DAY
266
DELISTED
Dayforce
DAY
$9.28M 0.06%
137,662
+122,055
+782% +$8.66M
ITOS
267
DELISTED
iTeos Therapeutics
ITOS
$9.26M 0.06%
739,517
KURA icon
268
Kura Oncology
KURA
$793M
$9.17M 0.06%
814,364
RXDX
269
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
$8.89M 0.06%
90,000
+15,000
+20% +$1.73M
KHC icon
270
Kraft Heinz
KHC
$32.8B
$8.86M 0.06%
248,933
+335
+0.1% +$13.3K
SPG icon
271
Simon Property Group
SPG
$76.4B
$8.85M 0.06%
85,918
+48,558
+130% +$5.8M
WTRG icon
272
Essential Utilities
WTRG
$11.5B
$8.85M 0.06%
220,222
+158,566
+257% +$7.15M
KDP icon
273
Keurig Dr Pepper
KDP
$42.8B
$8.73M 0.06%
268,800
-52,791
-16% -$1.86M
SJR
274
DELISTED
Shaw Communications Inc.
SJR
$8.62M 0.06%
313,241
+227,650
+266% +$6.6M
BSY icon
275
Bentley Systems
BSY
$11.2B
$8.54M 0.06%
215,856
-47,424
-18% -$1.89M

Similar funds

Candriam SCA's Q1 2023 Portfolio in Review

As of Q1 2023, Candriam SCA held 957 positions worth $14.4B, down 2.7% from $14.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Candriam SCA's Q1 2023 filing shows 98 new, 341 increased, 353 reduced and 82 closed positions. Its largest new stake was Kanzhun: 2,106,130 shares worth $36.9M. The largest sale was Mercado Libre, an estimated $79.9M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2023 buy was Kanzhun: 2,106,130 shares worth $36.9M.
  • Candriam SCA added most to SunOpta in Q1 2023, an estimated $45M increase.
  • Candriam SCA's biggest Q1 2023 reduction was Mercado Libre, cutting an estimated $79.9M.
  • Candriam SCA fully exited Veru in Q1 2023, selling an estimated $53.9M.
  • Candriam SCA's ten largest holdings make up 24% of its $14.4B portfolio in Q1 2023.
  • Candriam SCA opened 98 new positions and closed 82 in Q1 2023.
  • Candriam SCA's portfolio value fell 2.7% quarter-over-quarter to $14.4B.

Based on Candriam SCA's 13F filing for Q1 2023, filed 12 May 2023.